These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38978350)

  • 1. PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients.
    Ferreres JR; Vinyals A; Campos-Martin R; Espín R; Podlipnik S; Ramos R; Bertran E; Carrera C; Marcoval J; Malvehy J; Fabregat I; Puig S; Fabra À
    Mol Oncol; 2024 Oct; 18(10):2471-2494. PubMed ID: 38978350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
    Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.
    Ocaña OH; Córcoles R; Fabra A; Moreno-Bueno G; Acloque H; Vega S; Barrallo-Gimeno A; Cano A; Nieto MA
    Cancer Cell; 2012 Dec; 22(6):709-24. PubMed ID: 23201163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRRX1 Regulates Cellular Phenotype Plasticity and Dormancy of Head and Neck Squamous Cell Carcinoma Through miR-642b-3p.
    Jiang J; Zheng M; Zhang M; Yang X; Li L; Wang SS; Wu JS; Yu XH; Wu JB; Pang X; Tang YJ; Tang YL; Liang XH
    Neoplasia; 2019 Feb; 21(2):216-229. PubMed ID: 30622052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer.
    Takahashi Y; Sawada G; Kurashige J; Uchi R; Matsumura T; Ueo H; Takano Y; Akiyoshi S; Eguchi H; Sudo T; Sugimachi K; Doki Y; Mori M; Mimori K
    Br J Cancer; 2013 Jul; 109(2):307-11. PubMed ID: 23807160
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Meng Z; Chen Y; Wu W; Yan B; Zhang L; Chen H; Meng Y; Liang Y; Yao X; Luo J
    Front Immunol; 2022; 13():754645. PubMed ID: 35281030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRRX1 promotes lymph node metastasis of gastric cancer by regulating epithelial-mesenchymal transition.
    Yao J; Zhang Y; Xia Y; Zhu C; Wen X; Liu T; Da M
    Medicine (Baltimore); 2021 Feb; 100(6):e24674. PubMed ID: 33578599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
    Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
    Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells.
    Perotti V; Baldassari P; Molla A; Nicolini G; Bersani I; Grazia G; Benigni F; Maurichi A; Santinami M; Anichini A; Mortarini R
    Oncogene; 2019 May; 38(22):4384-4396. PubMed ID: 30710146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
    Lv ZD; Kong B; Liu XP; Jin LY; Dong Q; Li FN; Wang HB
    J Cell Mol Med; 2016 May; 20(5):864-73. PubMed ID: 26820102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid synthase contributes to epithelial-mesenchymal transition and invasion of salivary adenoid cystic carcinoma through PRRX1/Wnt/β-catenin pathway.
    Zhang WL; Wang SS; Jiang YP; Liu Y; Yu XH; Wu JB; Wang K; Pang X; Liao P; Liang XH; Tang YL
    J Cell Mol Med; 2020 Oct; 24(19):11465-11476. PubMed ID: 32820613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT.
    Kosnopfel C; Sinnberg T; Sauer B; Busch C; Niessner H; Schmitt A; Forchhammer S; Grimmel C; Mertens PR; Hailfinger S; Dunn SE; Garbe C; Schittek B
    Mol Cancer Res; 2018 Jul; 16(7):1149-1160. PubMed ID: 29743296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.
    Gong C; Shen J; Fang Z; Qiao L; Feng R; Lin X; Li S
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29899166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
    Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
    Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
    Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
    Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
    Lv ZD; Yang ZC; Liu XP; Jin LY; Dong Q; Qu HL; Li FN; Kong B; Sun J; Zhao JJ; Wang HB
    J Cell Mol Med; 2016 Sep; 20(9):1640-50. PubMed ID: 27027510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP27 associates with epithelial-mesenchymal transition, stemness and radioresistance of salivary adenoid cystic carcinoma.
    Chen W; Ren X; Wu J; Gao X; Cen X; Wang S; Sheng S; Chen Q; Tang YJ; Liang XH; Tang YL
    J Cell Mol Med; 2018 Apr; 22(4):2283-2298. PubMed ID: 29424489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regualtion of miR-106b induces epithelial-mesenchymal transition but suppresses metastatic colonization by targeting Prrx1 in colorectal cancer.
    Zheng L; Zhang Y; Lin S; Sun A; Chen R; Ding Y; Ding Y
    Int J Clin Exp Pathol; 2015; 8(9):10534-44. PubMed ID: 26617763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.